Delivery Order SPE2DB22D1106-SPE2DB25FFAF7
- Not listed
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Omnipaque 240 mg/ml vials (10 ml units) at a ceiling value of $1,200.00. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 11, 2025, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,239.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 300 mg/ml in 100ml infusion bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 15, 2025. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml infusion bottles (100 ml units). The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,044.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 240 mg/ml vials (10 ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This delivery order is classified as non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,814.91 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This non-competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,352.64 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete...
- This is a $6,378.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through June 17, 2024. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,541.42 delivery order to AmerisourceBergen Drug Corp for Omnipaque 350 mg/mL PlushPak 500mL, a diagnostic imaging contrast agent used in medical radiological procedures. This competitively awarded, firm fixed-price contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAF7Delivery Order
The Defense Logistics Agency awarded a $1,200 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OMNIPAQUE 240 mg/ml vials in 10 ml quantities. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and performance location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion agreement running through December 2026 that serves as a comprehensive global pharmaceutical support program for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement with an extensive portfolio of pharmaceutical and medical supply deliveries. The company maintains consistent competitively awarded delivery orders with the Defense Logistics Agency across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This particular award for OMNIPAQUE, a contrast imaging agent, reflects the company's role in supporting military and veteran healthcare systems through flexible contract vehicles that enable delivery of diverse pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/29/25 |